Correlation Between BioMark Diagnostics and Enzo Biochem

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BioMark Diagnostics and Enzo Biochem at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioMark Diagnostics and Enzo Biochem into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioMark Diagnostics and Enzo Biochem, you can compare the effects of market volatilities on BioMark Diagnostics and Enzo Biochem and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioMark Diagnostics with a short position of Enzo Biochem. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioMark Diagnostics and Enzo Biochem.

Diversification Opportunities for BioMark Diagnostics and Enzo Biochem

-0.02
  Correlation Coefficient

Good diversification

The 3 months correlation between BioMark and Enzo is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding BioMark Diagnostics and Enzo Biochem in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enzo Biochem and BioMark Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioMark Diagnostics are associated (or correlated) with Enzo Biochem. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enzo Biochem has no effect on the direction of BioMark Diagnostics i.e., BioMark Diagnostics and Enzo Biochem go up and down completely randomly.

Pair Corralation between BioMark Diagnostics and Enzo Biochem

Assuming the 90 days horizon BioMark Diagnostics is expected to generate 2.79 times more return on investment than Enzo Biochem. However, BioMark Diagnostics is 2.79 times more volatile than Enzo Biochem. It trades about 0.01 of its potential returns per unit of risk. Enzo Biochem is currently generating about -0.02 per unit of risk. If you would invest  19.00  in BioMark Diagnostics on September 14, 2024 and sell it today you would lose (4.00) from holding BioMark Diagnostics or give up 21.05% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy99.6%
ValuesDaily Returns

BioMark Diagnostics  vs.  Enzo Biochem

 Performance 
       Timeline  
BioMark Diagnostics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BioMark Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's fundamental indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
Enzo Biochem 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Enzo Biochem are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, Enzo Biochem is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

BioMark Diagnostics and Enzo Biochem Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BioMark Diagnostics and Enzo Biochem

The main advantage of trading using opposite BioMark Diagnostics and Enzo Biochem positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioMark Diagnostics position performs unexpectedly, Enzo Biochem can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enzo Biochem will offset losses from the drop in Enzo Biochem's long position.
The idea behind BioMark Diagnostics and Enzo Biochem pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk